ACETIC ACID- acetic acid solution Marekani - Kiingereza - NLM (National Library of Medicine)

acetic acid- acetic acid solution

a-s medication solutions - acetic acid (unii: q40q9n063p) (acetic acid - unii:q40q9n063p) - acetic acid 20 mg in 1 ml - for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial. hypersensitivity to acetic acid otic solution or any of the ingredients. perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

SYNTHAMIN 9 Amino acid with Electrolytes 500mL injection AHA6925 Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

synthamin 9 amino acid with electrolytes 500ml injection aha6925

baxter healthcare pty ltd - leucine, quantity: 4.02 g/l; phenylalanine, quantity: 3.08 g/l; methionine, quantity: 2.2 g/l; lysine hydrochloride, quantity: 3.99 g/l (equivalent: lysine, qty 3.19 g/l); isoleucine, quantity: 3.3 g/l; valine, quantity: 3.19 g/l; histidine, quantity: 2.64 g/l; threonine, quantity: 2.31 g/l; tryptophan, quantity: 990 mg/l; alanine, quantity: 11.4 g/l; glycine, quantity: 5.66 g/l; arginine, quantity: 6.32 g/l; proline, quantity: 3.74 g/l; tyrosine, quantity: 220 mg/l; serine, quantity: 2.75 g/l; sodium aceta - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

SYNTHAMIN 17 Amino acid 10% with electrolytes 500mL injection AHA6921 Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

synthamin 17 amino acid 10% with electrolytes 500ml injection aha6921

baxter healthcare pty ltd - leucine, quantity: 7.3 g/l; phenylalanine, quantity: 5.6 g/l; methionine, quantity: 4 g/l; lysine hydrochloride, quantity: 7.24 g/l (equivalent: lysine, qty 5.8 g/l); isoleucine, quantity: 6 g/l; valine, quantity: 5.8 g/l; histidine, quantity: 4.8 g/l; threonine, quantity: 4.2 g/l; tryptophan, quantity: 1.8 g/l; alanine, quantity: 20.7 g/l; glycine, quantity: 10.3 g/l; arginine, quantity: 11.5 g/l; proline, quantity: 6.8 g/l; tyrosine, quantity: 400 mg/l; serine, quantity: 5 g/l; sodium acetate, quantity: 6 - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

TRIOMEL PERIPHERAL 4G/L Nitrogen 700KCAL/L with electrolytes, emulsion for infusion Malta - Kiingereza - Medicines Authority

triomel peripheral 4g/l nitrogen 700kcal/l with electrolytes, emulsion for infusion

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, phenylalanine, potassium chloride, histidine, arginine, aspartic acid, olive oil, threonine, tryptophan, tyrosine, valine, glucose monohydrate, glutamic acid, glycine, methionine, isoleucine, lysine, magnesium chloride, hexahydrate, serine, proline, sodium acetate, trihydrate, sodium glycerophosphate, soybean oil - emulsion for infusion - tryptophan tyrosine valine glucose monohydrate glutamic acid glycine methionine isoleucine lysine magnesium chloride hexahydrate serine proline sodium acetate trihydrate sodium glycerophosphate soybean oil calcium chloride dihydrate phenylalanine potassium chloride histidine arginine aspartic acid olive oil alanine threonine - blood substitutes and perfusion solutions

Kabiven G11% Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

kabiven g11%

fresenius kabi new zealand limited - glucose monohydrate 12.1% equivalent to 11% glucose anhydrous;  ;  ;  ; alanine 1.6%;  ;  ;  ; arginine 1.13%;  ;  ;  ;  ; aspartic acid 0.34%;  ;  ;  ;  ;  ; calcium chloride dihydrate 0.074%;  ; glutamic acid 0.56%;  ;  ;  ;  ;  ; glycine 0.79%;  ;  ;  ;  ;  ; histidine 0.68%;  ;  ;  ;  ; isoleucine 0.56%;  ;  ;  ;  ;  ; leucine 0.79%;  ;  ;  ;  ;  ; lysine hydrochloride 0.9%;  ;  ;  ;  ;  ;  ; magnesium sulfate heptahydrate 0.16%;  ;  ; methionine 0.56%;  ;  ;  ;  ;  ; phenylalanine 0.79%;  ;  ;  ;  ;  ;  ; potassium chloride 0.597%;  ; proline 0.68%;  ; serine 0.45%;  ;  ;  ;  ;  ; sodium acetate trihydrate 0.49%;  ;  ; sodium glycerophosphate 0.54%;  ;  ; threonine 0.56%;  ;  ;  ; tryptophan 0.19%;  ;  ;  ; tyrosine 0.023%;  ;  ;  ; valine 0.73%;  ;  ;  ;  ; soya oil 20% - emulsion for injection - active: glucose monohydrate 12.1% equivalent to 11% glucose anhydrous       excipient: water for injection active: alanine 1.6%       arginine 1.13%         aspartic acid 0.34%           calcium chloride dihydrate 0.074%   glutamic acid 0.56%           glycine 0.79%           histidine 0.68%         isoleucine 0.56%           leucine 0.79%           lysine hydrochloride 0.9%             magnesium sulfate heptahydrate 0.16%     methionine 0.56%           phenylalanine 0.79%             potassium chloride 0.597%   proline 0.68%   serine 0.45%           sodium acetate trihydrate 0.49%     sodium glycerophosphate 0.54%     threonine 0.56%       tryptophan 0.19%       tyrosine 0.023%       valine 0.73%         excipient: glacial acetic acid water for injection active: soya oil 20% excipient: egg lecithin glycerol sodium hydroxide water for injection - parenteral nutrition for adult patients and children above 2 years of age when oral or enteral nutrition is impossible or insufficient or contraindicated.

Kabiven G19% Nyuzilandi - Kiingereza - Medsafe (Medicines Safety Authority)

kabiven g19%

fresenius kabi new zealand limited - glucose monohydrate 20.9% equivalent to 19% glucose anhydrous;  ;  ;  ; alanine 1.6%;  ;  ;  ; arginine 1.13%;  ;  ;  ;  ; aspartic acid 0.34%;  ;  ;  ;  ;  ; calcium chloride dihydrate 0.074%;  ; glutamic acid 0.56%;  ;  ;  ;  ;  ; glycine 0.79%;  ;  ;  ;  ;  ; histidine 0.68%;  ;  ;  ;  ; isoleucine 0.56%;  ;  ;  ;  ;  ; leucine 0.79%;  ;  ;  ;  ;  ; lysine hydrochloride 0.9%;  ;  ;  ;  ;  ;  ; magnesium sulfate heptahydrate 0.16%;  ;  ; methionine 0.56%;  ;  ;  ;  ;  ; phenylalanine 0.79%;  ;  ;  ;  ;  ; potassium chloride 0.597%;  ; proline 0.68%;  ; serine 0.45%;  ;  ;  ;  ; sodium acetate trihydrate 0.49%;  ;  ; sodium glycerophosphate 0.54%;  ;  ;  ; threonine 0.56%;  ;  ;  ; tryptophan 0.19%;  ;  ;  ; tyrosine 0.023%;  ;  ;  ; valine 0.73%;  ;  ;  ;  ; soya oil 20% - emulsion for injection - active: glucose monohydrate 20.9% equivalent to 19% glucose anhydrous       excipient: water for injection active: alanine 1.6%       arginine 1.13%         aspartic acid 0.34%           calcium chloride dihydrate 0.074%   glutamic acid 0.56%           glycine 0.79%           histidine 0.68%         isoleucine 0.56%           leucine 0.79%           lysine hydrochloride 0.9%             magnesium sulfate heptahydrate 0.16%     methionine 0.56%           phenylalanine 0.79%           potassium chloride 0.597%   proline 0.68%   serine 0.45%         sodium acetate trihydrate 0.49%     sodium glycerophosphate 0.54%       threonine 0.56%       tryptophan 0.19%       tyrosine 0.023%       valine 0.73%         excipient: glacial acetic acid water for injection active: soya oil 20% excipient: egg lecithin glycerol sodium hydroxide water for injection - parenteral nutrition for adult patients and children above 2 years of age when oral or enteral nutrition is impossible or insufficient or contraindicated.

SYNTHAMIN 17 WITHOUT ELECTROLYTES 10% AMINO ACID INTRAVENOUS INFUSION Singapoo - Kiingereza - HSA (Health Sciences Authority)

synthamin 17 without electrolytes 10% amino acid intravenous infusion

baxter healthcare (asia) pte ltd - aminoacetic acid (glycine); l-alanine; l-arginine; l-histidine; l-isoleucine; l-leucine; l-lysine hcl eqv l-lysine; l-methionine; l-phenylalanine; l-proline; l-serine; l-threonine; l-tryptophan; l-tyrosine; l-valine - injection - 10.30 g/l - aminoacetic acid (glycine) 10.30 g/l; l-alanine 20.70 g/l; l-arginine 11.50 g/l; l-histidine 4.80 g/l; l-isoleucine 6.00 g/l; l-leucine 7.30 g/l; l-lysine hcl eqv l-lysine 5.80 g/l; l-methionine 4.00 g/l; l-phenylalanine 5.60 g/l; l-proline 6.80 g/l; l-serine 5.00 g/l; l-threonine 4.20 g/l; l-tryptophan 1.80 g/l; l-tyrosine 0.40 g/l; l-valine 5.80 g/l

KETOL Nyuzilandi - Kiingereza - Ministry for Primary Industries

ketol

elanco new zealand - potassium glycerophosphate; ethylenediamine dihydroiodide; sodium glycerophosphate; magnesium glycerophosphate; ferric glycerophosphate; calcium glycerophosphate; cobalt sulphate heptahydrate; choline chloride; acetic acid; propylene glycol - potassium glycerophosphate 0.07 g/litre; ethylenediamine dihydroiodide 0.44 g/litre; sodium glycerophosphate 0.04 g/litre; magnesium glycerophosphate 0.03 g/litre; ferric glycerophosphate 0.03 g/litre; calcium glycerophosphate 0.14 g/litre; cobalt sulphate heptahydrate 1.1 g/litre; choline chloride 20.6 g/litre; acetic acid 0.39 g/litre; propylene glycol 828.8 g/litre - oral nutrient/electrolyte

SMOFKABIVEN NTENSE amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2531 mL bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2531 ml bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated

SMOFKABIVEN NTENSE amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2025 mL bag Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

smofkabiven ntense amino acid 6.5% with 0.7% electrolytes, lipids 2.9% & glucose 8.5 % emulsion for intravenous infusion 2025 ml bag

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; olive oil, quantity: 50 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: dl-alpha-tocopherol; egg lecithin; glycerol; sodium hydroxide; sodium oleate; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated